Health Care in an Evolving Cyber Threat Landscape: FDA and Industry Perspectives
No ratings
Presented at GlobalPrivacySummit 2019 by
No area of cybersecurity and data privacy presents higher stakes than medical devices. Underlying the obvious risks to patient safety are myriad business and legal challenges spanning operational and data security, privacy and liability, all arising in a complex industry setting involving patients, manufacturers, medical providers, security professionals, lawyers and the FDA itself. In this session, the audience will have the opportunity to learn from and engage with a panel of experts from the FDA, Boston Scientific and the Cleveland Clinic, moderated by cybersecurity counsel from Debevoise & Plimpton. You will hear about the latest approaches to vulnerability disclosure and risk management, how manufacturers and providers work together to mitigate risks, why cyber risk for patient care is different than cyber risk for data, as well as new FDA guidance and insights.What you’ll take away:The legal landscape that applies to the security of connected medical devicesKey cyber threats and privacy implications that organizations should consider when purchasing connected devicesUnderstanding the FDA guidance on medical device cybersecurity and how FDA and industry interact on these issues